Related references
Note: Only part of the references are listed.AGC kinases, mechanisms of regulation and innovative drug development
Alejandro E. Leroux et al.
SEMINARS IN CANCER BIOLOGY (2018)
PDK1: At the crossroad of cancer signaling pathways
Paolo Armando Gagliardi et al.
SEMINARS IN CANCER BIOLOGY (2018)
Dual Inhibition of PDK1 and Aurora Kinase A: An Effective Strategy to Induce Differentiation and Apoptosis of Human Glioblastoma Multiforme Stem Cells
Simona Daniele et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Akt activation by Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) in ovarian cancer cells
Angela M. Gocher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
PDK1 inhibitor GSK2334470 exerts antitumor activity in multiple myeloma and forms a novel multitargeted combination with dual mTORC1/C2 inhibitor PP242
Chunmei Yang et al.
ONCOTARGET (2017)
TCRP1 promotes NIH/3T3 cell transformation by over-activating PDK1 and AKT1
C. Wang et al.
ONCOGENESIS (2017)
Timp1 Promotes Cell Survival by Activating the PDK1 Signaling Pathway in Melanoma
Mariana Toricelli et al.
CANCERS (2017)
Serine/Threonine Kinase 3-Phosphoinositide-Dependent Protein Kinase-1 (PDK1) as a Key Regulator of Cell Migration and Cancer Dissemination
Laura Di Blasio et al.
CANCERS (2017)
Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer
Valerie M. Jansen et al.
CANCER RESEARCH (2017)
Amino acid transporter SLC38A3 promotes metastasis of non-small cell lung cancer cells by activating PDK1
Yanhui Wang et al.
CANCER LETTERS (2017)
Abstract C198: PDK1 inhibitors SNS-229 and SNS-510 cause pathway modulation, apoptosis and tumor regression in hematologic cancer models in addition to solid tumors
Stig Hansen et al.
MOLECULAR CANCER THERAPEUTICS (2016)
PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition
Pau Castel et al.
CANCER CELL (2016)
The hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumourgrowth
Ruzica Bago et al.
EMBO JOURNAL (2016)
Correlation of PDK1 expression with clinicopathologic features and prognosis of hepatocellular carcinoma
Junrong Wang et al.
ONCOTARGETS AND THERAPY (2016)
A Small Molecule Inhibitor of PDK1/PLCγ1 Interaction Blocks Breast and Melanoma Cancer Cell Invasion
Claudio Raimondi et al.
SCIENTIFIC REPORTS (2016)
Phosphoinositide-dependent kinase 1 regulates leukemia stem cell maintenance in MLL-AF9-induced murine acute myeloid leukemia
Tianyuan Hu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
PDK1: A signaling hub for cell migration and tumor invasion
Paolo Armando Gagliardi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2015)
PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets
Marzia Scortegagna et al.
CANCER RESEARCH (2015)
Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme
Simona Sestito et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Regulation of mTORC1 by PI3K signaling
Christian C. Dibble et al.
TRENDS IN CELL BIOLOGY (2015)
PDK1 induces JunB, EMT, cell migration and invasion in human gallbladder cancer
Shixian Lian et al.
ONCOTARGET (2015)
COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization
Yi-Hui Wu et al.
ONCOTARGET (2015)
TCRP1 contributes to cisplatin resistance by preventing Pol β degradation in lung cancer cells
Xiaorong Liu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
AACR-NCI-EORTC-27TH INTERNATIONAL SYMPOSIUM - MOLECULAR TARGETS AND CANCER THERAPEUTICS (NOVEMBER 5-9, 2015-BOSTON, MASSACHUSETTS, USA)
V. Carceller
DRUGS OF TODAY (2015)
Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells
Padmamalini Thulasiraman et al.
BMC CANCER (2014)
The PDK1 master kinase is over-expressed in acute myeloid leukemia and promotes PKC-mediated survival of leukemic blasts
Joanna Zabkiewicz et al.
HAEMATOLOGICA (2014)
BRAFV600E Cooperates with PI3K Signaling, Independent of AKT, to Regulate Melanoma Cell Proliferation
Jillian M. Silva et al.
MOLECULAR CANCER RESEARCH (2014)
PI3K and cancer: lessons, challenges and opportunities
David A. Fruman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
FOXO transcription factors: key regulators of cellular quality control
Ashley E. Webb et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Emerging role of the KRAS-PDK1 axis in pancreatic cancer
Riccardo Ferro et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo
M. Signore et al.
CELL DEATH & DISEASE (2014)
Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors
Eeva M. Sommer et al.
BIOCHEMICAL JOURNAL (2013)
AGC protein kinases: From structural mechanism of regulation to allosteric drug development for the treatment of human diseases
Jose M. Arencibia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2013)
Selective Requirement of PI3K/PDK1 Signaling for Kras Oncogene-Driven Pancreatic Cell Plasticity and Cancer
Stefan Eser et al.
CANCER CELL (2013)
The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
Zachary C. Dobbin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Interaction of PDK1 with Phosphoinositides Is Essential for Neuronal Differentiation but Dispensable for Neuronal Survival
Tinatin Zurashvili et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases
Mathea Pietri et al.
NATURE MEDICINE (2013)
Activation of PDK-1 maintains mouse embryonic stem cell self-renewal in a PKB-dependent manner
L. S. Ling et al.
ONCOGENE (2013)
Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1
Run Fan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
mTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in PIK3CA-Mutant Breast Cancer
Moshe Elkabets et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Synthesis of Novel 3,5-Disubstituted-2-oxindole Derivatives As Antitumor Agents against Human Nonsnnall Cell Lung Cancer
Giulia Nesi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
PDK1 Signaling Toward PLK1-MYC Activation Confers Oncogenic Transformation, Tumor-Initiating Cell Activation, and Resistance to mTOR-Targeted Therapy
Jing Tan et al.
CANCER DISCOVERY (2013)
Akt is efficiently activated by PIF-pocket- and PtdIns(3,4,5)P3-dependent mechanisms leading to resistance to PDK1 inhibitors
Ayaz Najafov et al.
BIOCHEMICAL JOURNAL (2012)
The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease Progression
Khalil A. Choucair et al.
TRANSLATIONAL ONCOLOGY (2012)
3-Phosphoinositide-Dependent Kinase 1 Controls Breast Tumor Growth in a Kinase-Dependent but Akt-Independent Manner
Paolo Armando Gagliardi et al.
NEOPLASIA (2012)
PDK1 inhibitors
Elisa Barile et al.
PHARMACEUTICAL PATENT ANALYST (2012)
Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1
Ayaz Najafov et al.
BIOCHEMICAL JOURNAL (2011)
PDK1 Attenuation Fails to Prevent Tumor Formation in PTEN-Deficient Transgenic Mouse Models
Katharine Ellwood-Yen et al.
CANCER RESEARCH (2011)
Targeting PDK1 in Cancer
C. Raimondi et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Genetic and Pharmacological Inhibition of PDK1 in Cancer Cells CHARACTERIZATION OF A SELECTIVE ALLOSTERIC KINASE INHIBITOR
Kumiko Nagashima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
TCRP1 promotes radioresistance of oral squamous cell carcinoma cells via Akt signal pathway
Yixue Gu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
X. Zhang et al.
ONCOGENE (2011)
Knockdown of MTDH Sensitizes Endometrial Cancer Cells to Cell Death Induction by Death Receptor Ligand TRAIL and HDAC Inhibitor LBH589 Co-Treatment
Xiangbing Meng et al.
PLOS ONE (2011)
Identification of Direct Target Engagement Biomarkers for Kinase-Targeted Therapeutics
Cloud P. Paweletz et al.
PLOS ONE (2011)
Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications
Taru A. Muranen et al.
BREAST CANCER RESEARCH (2011)
A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate
M. Falasca et al.
BRITISH JOURNAL OF CANCER (2010)
Cell Signaling by Receptor Tyrosine Kinases
Mark A. Lemmon et al.
CELL (2010)
The Hippo Signaling Pathway in Development and Cancer
Duojia Pan
DEVELOPMENTAL CELL (2010)
Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation
Kajsa Ericson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitization
Elizabeth Iorns et al.
BIOCHEMICAL JOURNAL (2009)
AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer
Krishna M. Vasudevan et al.
CANCER CELL (2009)
3-Phosphoinositide-Dependent Kinase 1 Potentiates Upstream Lesions on the Phosphatidylinositol 3-Kinase Pathway in Breast Carcinoma
Matthew Maurer et al.
CANCER RESEARCH (2009)
Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells
Tina X. Lee et al.
EUROPEAN JOURNAL OF CANCER (2009)
Environment-mediated drug resistance: a major contributor to minimal residual disease
Mark B. Meads et al.
NATURE REVIEWS CANCER (2009)
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
NATURE REVIEWS CANCER (2009)
New anti-cancer role for PDK1 inhibitors: preventing resistance to tamoxifen
Christian Peifer et al.
BIOCHEMICAL JOURNAL (2008)
An immunohistochemical perspective of PPARβ and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours
N. Ahmed et al.
BRITISH JOURNAL OF CANCER (2008)
TUSC4/NPRL2, a novel PDK1-interacting protein, inhibits PDK1 tyrosine phosphorylation and its downstream signaling
Atsuo Kurata et al.
CANCER SCIENCE (2008)
Module map of stem cell genes guides creation of epithelial cancer stem cells
David J. Wong et al.
CELL STEM CELL (2008)
Role of PDK1 in Regulation of Gastric Acid Secretion
Anand Rotte et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2008)
Small-Molecule Inhibitors of PDK1
Christian Peifer et al.
CHEMMEDCHEM (2008)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
Freud-1/Aki1, a novel PDK1-interacting protein, functions as a scaffold to activate the PDK1/Akt pathway in epidermal growth factor signaling
Akito Nakamura et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Mutation of the PDK1 PH domain inhibits protein kinase B/Akt, leading to small size and insulin resistance
Jose R. Bayascas et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
被撤回的出版物: Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor (Retracted article. See vol. 18, pg. 869, 2019)
Shu-Chuan Weng et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy
J. A. McCubrey et al.
LEUKEMIA (2008)
PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE
Sophie Pinner et al.
NATURE CELL BIOLOGY (2008)
Restoration of glucokinase expression in the liver normalizes postprandial glucose disposal in mice with hepatic deficiency of PDK1
Yasuo Okamoto et al.
DIABETES (2007)
Chemopreventive and bioenergetic signaling effects of PDK1/Akt pathway inhibition in a transgenic mouse model of prostate cancer
Aaron M. Sargeant et al.
TOXICOLOGIC PATHOLOGY (2007)
Impaired intestinal NHE3 activity in the PDK1 hypomorphic mouse
Ciprian Sandu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia
Steven M. Kornblau et al.
BLOOD (2006)
Evaluation of approaches to generation of tissue-specific knock-in mice
Jose R. Bayascas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Differential roles of phosphoinositide-dependent protein kinase-1 and Akt1 expression and phosphorylation in breast cancer cell resistance to paclitaxel, doxorubicin, and gemcitabine
Ke Liang et al.
MOLECULAR PHARMACOLOGY (2006)
Role of the PH domain in regulating in vitro autophosphorylation events required for reconstitution of PDK1 catalytic activity
Xinxin Gao et al.
BIOORGANIC CHEMISTRY (2006)
Ablation of PDK1 in pancreatic β cells induces diabetes as a result of loss of β cell mass
N Hashimoto et al.
NATURE GENETICS (2006)
Elevated phosphorylation and activation of PDK-I/AKT pathway in human breast cancer
HJ Lin et al.
BRITISH JOURNAL OF CANCER (2005)
Hypomorphic mutation of PDK1 suppresses tumorigenesis in PTEN+/- mice
JR Bayascas et al.
CURRENT BIOLOGY (2005)
Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects
T Maffucci et al.
CANCER RESEARCH (2005)
Mutant PIK3CA promotes cell growth and invasion of human cancer cells
Y Samuels et al.
CANCER CELL (2005)
Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1
RI Feldman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-κB, MAPkinase and p53 pathways
VL Grandage et al.
LEUKEMIA (2005)
Deficiency of PDK1 in liver results in glucose intolerance, impairment of insulin-regulated gene expression and liver failure
A Mora et al.
BIOCHEMICAL JOURNAL (2005)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
Phosphoinositide-dependent protein kinase 1, a sensor of protein conformation
RM Biondi
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3
JT Murray et al.
BIOCHEMICAL JOURNAL (2004)
From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-pliosphoinositide-dependent protein kinase-1 inhibitors (Publication with Expression of Concern. See vol. 79, pg. 1716, 2019)
JX Zhu et al.
CANCER RESEARCH (2004)
Structural insights into the regulation of PDK1 by phosphoinositides and inositol phosphates
D Komander et al.
EMBO JOURNAL (2004)
The in vivo role of PtdIns(3,4,5)P3 binding to PDK1 PH domain defined by knockin mutation
EJ McManus et al.
EMBO JOURNAL (2004)
Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia
A Mora et al.
EMBO JOURNAL (2003)
Sensitization of human breast cancer cells to gemcitabine by the protein kinase C modulator bryostatin 1
S Ali et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2003)
In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation
BJ Collins et al.
EMBO JOURNAL (2003)
Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome
JW Cheong et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Regulation of kinase activity of 3-phosphoinositide-dependent protein kinase-1 by binding to 14-3-3
S Sato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Essential role of PDK1 in regulating cell size and development in mice
MA Lawlor et al.
EMBO JOURNAL (2002)
Involvement of Hsp90 in signaling and stability of 3-phosphoinositide-dependent kinase-1
N Fujita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?
MJ Fry
BREAST CANCER RESEARCH (2001)
Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo
A Prokop et al.
LEUKEMIA (2000)
Share Paper
